Acute heart failure in surgery of coronary artery disease

Gazizova V.P.; Vlasova E.E.; Shiryaev A.A.; Akchurin R.S.

doi:https://doi.org/10.17116/Cardiobulletin2022170315

Close metadata

Recommended articles:

In-hospital results of coronary artery bypass grafting in patients with coronary artery disease and unverified distal coronary bed. Russian Cardiology Bulletin. 2025;(1):81-89

Left anterior descending artery and diagonal branch bypass in multiple-vessel coronary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):646-650

Moderate ischemic mitral insufficiency with severe left ventricular dysfunction: surgical treatment depending on predictors of adverse long-term outcomes. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):651-659

A comparative assessment of neurochemical and neurophysiological parameters of cardiac surgery patients who underwent different versions of multitasking cognitive training. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):62-68

Stentectomy following percutaneous coronary intervention complicated by perforation of distal anastomosis after previous coronary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):109-114

Hemodynamic parameters of venous return and their role in assessment of fluid responsiveness in cardiac surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):6-12

Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80

Strain echocardiography for perioperative assessment of the left ventricle and left atrium in patients undergoing coronary artery bypass surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):269-279

Immediate results of coronary bypass grafting without touching the aorta in patients with multiple-vessel disease: a single-center retrospective study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):280-285

Optimal cardioplegia for coronary artery bypass grafting in patients with heart failure: a randomized study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):405-411

Abstract:

Perioperative acute heart failure or low cardiac output syndrome occurs in 9—20% patients after coronary artery bypass surgery. It is an important postoperative complication increasing in-hospital mortality and significantly aggravating early postoperative period. Patients with multiple-vessel coronary artery disease and low left ventricular ejection fraction caused by extensive scaring lesions and hibernation of the viable myocardium comprise a separate group in coronary surgery. Complete surgical revascularization is preferred in these patients, as it improves the long-term prognosis of life. At the same time, this procedure is associated with higher risk of perioperative heart failure and in-hospital mortality. Searching for the best method reducing this risk is being continued. This review is devoted to effectiveness of coronary artery bypass grafting in patients with low left ventricular contractility, methods of preparing for surgery, the role and methods of diagnosing a viable myocardium. Risk factors of perioperative acute heart failure, methods of its diagnosis and treatment are discussed.

Keywords:

coronary artery bypass grafting

viable myocardium

perioperative acute heart failure

low cardiac output syndrome

Authors:

Gazizova V.P.

Chazov National Medical Research Center of Cardiology

Vlasova E.E.

National Medical Research Center of Cardiology

RSCI AuthorID: 289380
Scopus AuthorID: 7006174730
ORCID: 0000-0003-2925-244X

Shiryaev A.A.

Chazov National Medical Research Centre of Cardiology

ORCID: 0000-0002-3325-9743

Akchurin R.S.

Chazov National Medical Research Centre of Cardiology

ORCID: 0000-0002-2105-8258

Received:

27.07.2022

Accepted:

08.08.2022

Close metadata

References:

Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL, STICHES Investigators. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. New England Journal of Medicine. 2016;374(16):1511-1520. https://doi.org/10.1056/NEJMoa1602001
Elefteriades JA, Tolls G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. American College of Cardiology. 1993;22(5):1411-1417. https://doi.org/10.1016/0735-1097(93)90551-b
2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87-165. https://doi.org/10.1093/eurheartj/ehy394
Bax JJ, Poldermans D, van der Wall EE. Evaluation of hibernating myocardium. Heart. 2004;90(11):1239-1240. https://doi.org/10.1136/hrt.2004.035998
Gazizova VP, Vlasova EE, Dzybinskaya EV, Gramovich VV, Stukalova OV, Shiryaev AA, Akchurin RS. The possibilities of using levosimendan in medical preparation to Coronary Artery Bypass Grafting in coronary artery disease patients with low left ventricular ejection fraction. Therapeutic Archive. 2020;92(1):43-48. (In Russ.). https://doi.org/10.26442/00403660.2020.01.000492
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. Journal of the American College of Cardiology. 2002;39(7):1151-1158. https://doi.org/10.1016/s0735-1097(02)01726-6
Romero J, Xue X, Gonzalez W, Garcia MJ. CMR Imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease. A meta-analysis of prospective trials. JACC: Cardiovascular Imaging. 2012;5(5):494-508. https://doi.org/10.1016/j.jcmg.2012.02.009
Kozlova IA, Kharlamova IY. Natriuretic Peptides: Biochemistry, Physiology, Clinical Implication. General Reanimatology. 2009;5(1):89-97. (In Russ.). https://doi.org/10.15360/1813-9779-2009-1-89
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599-3726. https://doi.org/10.1093/eurheartj/ehab368
Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten S-E, Bobek I, De Hert S, Wieselthaler G, Schirmer U, von Segesser LK, Sander M, Poldermans D, Ranucci M, Karpati PCJ, Wouters P, Seeberger M, Schmid ER, Weder W, Follath F. Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care. 2010;14(2):201. https://doi.org/10.1186/cc8153
Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. The Journal of Thoracic and Cardiovascular Surgery. 1996;112(1):38-51. https://doi.org/10.1016/s0022-5223(96)70176-9
Ding W, Ji Q, Shi Y, Ma R. Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. International Heart Journal. 2015;56(2):144-149. https://doi.org/10.1536/ihj.14-231
Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years. Annals of Thoracic Surgery. 2011;92(5):1678-1684. https://doi.org/10.1016/j.athoracsur.2011.06.017
Charlson M, Krieger KH, Peterson JC, Hayes J, Isom OW. Predictors and outcomes of cardiac complications following elective coronary bypass grafting. Proceedings of the Association of American Physicians. 1999;111(6):622-632. https://doi.org/10.1046/j.1525-1381.1999.99130.x
Hernandez-Leiva E, Dennis R, Isaza D, Umana JP. Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic study. Journal of Cardiothoracic Surgery. 2013;8:170. https://doi.org/10.1186/1749-8090-8-170
Lomivorotov VV, Efremov SM, Boboshko VA, Leyderman IN, Lomivorotov VN, Cheung AT, Karaskov AM. Preoperative total lymphocyte count in peripheral blood as a predictor of poor outcome in adult cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2011;25(6):975-980. https://doi.org/10.1053/j.jvca.2010.12.006
Cuthbertson BH, Croal BL, Rae D, Gibson PH, McNeilly JD, Jeffrey RR, Smith WC, Prescott GJ, Buchan KG, El-Shafei H, Gibson GA, Hillis GS. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. British Journal of Anaesthesia. 2009;103(5):647-653. https://doi.org/10.1093/bja/aep234
Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. Journal of the American College of Cardiology. 2004;43(10):1873-1879. https://doi.org/10.1016/j.jacc.2003.12.048
Muehlschlegel JD, Perry TE, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesthesia & Analgesia. 2010;111(5):1101-1119. https://doi.org/10.1213/ANE.0b013e3181dd9516
Ding W, Ji Q, Shi Y, Ma R. Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. International Heart Journal. 2015;56(2):144-149. https://doi.org/10.1536/ihj.14-231
Sa MPBO, Nogueira JRC, Ferraz PE, Figueiredo OJ, Cavalcante WCP, Cavalcante TCP, da Silva HTT, Santos CA, Lima ROA, Vasconcelos FP, de Carvalho Lima R. Risk factors for low cardiac output syndrome after coronary artery bypass grafting surgery. Revista Brasileira de Cirurgia Cardiovascular. 2012;27(2):217-223. https://doi.org/10.5935/1678-9741.20120037
Pan W, Hindler K, Lee VV, Vaughn WK, Collard CD. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology. 2006;104(3):441-447. https://doi.org/10.1097/00000542-200603000-00010
Tolpin DA, Collard CD, Lee VV, Elayda MA, Pan W. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency. Journal of Thoracic and Cardiovascular Surgery. 2009;138(4):873-879. https://doi.org/10.1016/j.jtcvs.2009.02.019
Lomivorotov VV, Efremov SM, Boboshko VA, Nikolaev DA, Vedernikov PE, Lomivorotov VN, Karaskov AM. Evaluation of nutritional screening tools for patients scheduled for cardiac surgery. Nutrition. 2013;29(2):436-442. https://doi.org/10.1016/j.nut.2012.08.006
Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL Jr., Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, O’Connor CM. Effect of natriuretic peptide—guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial. JAMA. 2017;318(8):713-720. https://doi.org/10.1001/jama.2017.10565
Chen TH, Lin CL, Shih JJ, Shih JE-M, Chen C-H, Chang M-L, Chin C-H. Plasma B-type natriuretic peptide in predicting outcomes of elective coronary artery bypass surgery. Kaohsiung Journal of Medical Sciences. 2013;29(5):254-258. https://doi.org/10.1016/j.kjms.2012.09.003
Moroz VV, Nikiforov YuV, Krichevsky LA, Aseyev VM, Guseva OG, Burzhunova MG, Rybakov VYu. The Significance of the Cardiac Peptide NT-proBNP in the Assessment of Risk for Myocardial Revascularization in Patients with Decreased Left Ventricular Ejection Fraction. General Reanimatology. 2010;6(2):38-42. (In Russ.). https://doi.org/10.15360/1813-9779-2010-2-38
Eliasdottir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiologica Scandinavica. 2008;52(2):182-187. https://doi.org/10.1111/j.1399-6576.2007.01451.x
Krichevsky LA, Rybakov VYu, Guseva OG, Kharlamova IE, Lyamin AYu. Use of Levosimendan in Cardiac Anesthesiology. General Reanimatology. 2011;7(4):60-66. (In Russ.). https://doi.org/10.15360/1813-9779-2011-4-60
O’Connor CM, Gattis WA, Uretsky BF, Adams KF Jr., McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). American Heart Journal. 1999;138(1):78-86. https://doi.org/10.1016/s0002-8703(99)70250-4
King JB, Shah RU, Sainski-Nguyen A, Biskupiak J, Munger MA, Bress AP. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure. Pharmacotherapy. 2017;37(6):662-672. https://doi.org/10.1002/phar.1939
Nielsen DV, Torp-Pedersen C, Skals RK, Gerds TA, Karaliunaite Z, Jakobsen C-J. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality. Critical Care. 2018;22(1):51. https://doi.org/10.1186/s13054-018-1969-1
Pasyuga VV, Lomivorotov VV, Eremenko AA. Cardiac Protective Inotropic Therapy — Opportunities and Prospective of Using Levosimendan in Cardiac Surgery. Messenger of Anesthesiology and Resuscitation. 2016;13(2):70-77. (In Russ.). https://doi.org/10.21292/2078-5658-2016-13-2-70-77
Toller W, Heringlake M, Guarracino F, Algotsson L, Alvarez J, Argyriadou H, Ben-Gal T, Černý V, Cholley B, Eremenko A, Guerrero-Orriach JL, Järvelä K, Karanovic N, Kivikko M, Lahtinen P, Lomivorotov V, Mehta RH, Mušič Š, Pollesello P, Rex S, Riha H, Rudiger A, Salmenperä M, Szudi L, Tritapepe L, Wyncoll D, Öwall A. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. International Journal of Cardiology. 2015;184:323-326. https://doi.org/10.1016/j.ijcard.2015.02.022
Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Solal AC, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB, Januzzi J. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Medicine. 2016;42(2):147-163. https://doi.org/10.1007/s00134-015-4041-5
Chernyavsky AM, Nesmachny AS, Boboshko AV, Nikolaev DA, Boboshko VA, Efendiev VU, Podsosnikova TN, Ruzmatov TM. Surgical treatment of coronary heart disease in patients with low left ventricular ejection fraction on a working heart in conditions of artificial circulation: immediate results. Pathology of blood circulation and cardiac surgery. 2015;19(1):51-58. (In Russ.).
Marino PL. Intensive care. Edited by Zilber AP. Translated from English by M.: GEOTAR-Media; 2010;768. (In Russ.).
Krichevsky LA, Kozlov IA. Prediction of the Time of Cardiac Function Normalization after Surgery under Extracorporeal Circulation. General Reanimatology. 2007;3(6):153-156. (In Russ.). https://doi.org/10.15360/1813-9779-2007-6-153-156
Kozlov IA, Krichevsky LA, Dzybinskaya EV. Ten years of transesophageal echocardiography in Russian cardioanesthesiology. Pathology of blood circulation and cardiac surgery. 2014;18(3):76-81. (In Russ.).
Gardner RS, Walker NL, McDonagh TA. Heart failure. Edited by Tereshchenko SN. M.: MEDpress-Inform; 2014;316-331. (In Russ.).
Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen C-J. Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis. Anesthesiology. 2014;120(5):1098-108. https://doi.org/10.1097/ALN.0000000000000224
Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. American Journal of Cardiology. 2005;96(6A):47G-58G. https://doi.org/10.1016/j.amjcard.2005.07.021
Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circulation Research. 1975;36(1):185-196. https://doi.org/10.1161/01.res.36.1.185
Totaro RJ, Raper RF. Epinephrine-induced lactic acidosis following cardiopulmonary bypass. Critical Care Medicine. 1997;25(10):1693-1699. https://doi.org/10.1097/00003246-199710000-00019
Fukuoka T, Nishimura M, Imanaka H, Taenaka N, Yoshiya I, Takezawa J. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Critical Care Medicine. 1989;17(11):1104-1107. https://doi.org/10.1097/00003246-198911000-00003
Parissis JT, Farmakis D, Nieminen M. Classical inotropes and new cardiac enhancers. Heart Failure Reviews. 2007;12(2):149-156. https://doi.org/10.1007/s10741-007-9014-5
Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Medicine. 2011;37(2):290-301. https://doi.org/10.1007/s00134-010-2073-4
Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR, ESSENTIAL Investigators. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. European Heart Journal. 2009;30(24):3015-3026. https://doi.org/10.1093/eurheartj/ehp338
Rybka MM, Lobacheva GV. Levosimendan. The first 10 years in clinical practice. Anesthesiology and intensive care. 2015;60(5):80-84. (In Russ.).
Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenperä M. Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. European Heart Journal. 1998;19(4):660-668. https://doi.org/10.1053/euhj.1997.0806
Iasonidou C, Karakasis T, Vasiliadou G, Rizou M, Ambatzidou F, Kapravelos N. Hemodynamic effects of the new calcium sensitizer levosimendan in cardiosurgical ICU patients. Critical Care. 2004;8(suppl 1):86. https://doi.org/10.1186/cc2553
Papp Z, Édes I, Fruhwald S, De Hert SG, Salmenperä M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RHG, Meyer S, Algotsson L, Wikström BG, Jörgensen K, Filippatos G, Parissis JT, González MJG, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. International Journal of Cardiology. 2012;159(2):82-87. https://doi.org/10.1016/j.ijcard.2011.07.022
Nieminen MS, Altenberger J, Ben-Gal T, Böhmer A, Comin-Colet J, Dickstein K, Edes I, Fedele F, Fonseca C, García-González MJ, Giannakoulas G, Iakobishvili Z, Jääskeläinen P, Karavidas A, Kettner J, Kivikko M, Lund LH, Matskeplishvili ST, Metra M, Morandi F, Oliva F, Parkhomenko A, Parissis J, Pollesello P, Pölzl G, Schwinger RHG, Segovia J, Seidel M, Vrtovec B, Wikström G. Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus. International Journal of Cardiology. 2014;174(2):360-367. https://doi.org/10.1016/j.ijcard.2014.04.111
Merekin DN, Lomivorotov VV, Efremov SM, Kirov MY, Lomivorotov VN. Low cardiac output syndrome in cardiac surgery. Almanac of Clinical Medicine. 2019;47(3):276-297. (In Russ.). https://doi.org/10.18786/2072-0505-2019-47-035